Chemotherapy and PARP inhibitors may share some side effects, but there are some major differences between the two when it comes to treating ovarian cancer.
Ursula A. Matulonis, M.D.
Advertisement
Articles by Ursula A. Matulonis, M.D.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CURE
1
Radiation Oncologist Answers Top Questions About Radiation Therapy
2
5 Years of Breast Cancer Advances: A Timeline of FDA Approvals and What They Mean for Patients
3
What Patients Should Know About Nipple-Sparing Mastectomy for Breast Cancer
4
Former Hospital Executive on Risks Patients With Cancer Face After Discharge
5